Filing Flows › Praxis Precision Medicines (PRAX) › Next earnings date
Praxis Precision Medicines (PRAX) earnings on Nov 9, 2026: what to expect
Praxis Precision Medicines (PRAX) is expected to report earnings on Nov 9, 2026, tomorrow, for the quarter ending Sep 30, 2026. Analysts expect EPS of −$3.63 (−$5.60 to −$2.74, 19 estimates), against −$3.36 a year ago. It beat the EPS estimate in 75% of the quarters on record; Filing Flows' model gives it a 76% chance of beating next time.
What to watch
Last quarter (Q4 2024) the lines that make up revenue grew like this; the report shows whether the trend holds:
Filing Flows' own estimate from the SEC figures — the same quarter last year times recent growth — is EPS −$3.36, against the analysts' −$3.63.
The last report
Praxis Precision Medicines reported revenue of $7.5M for the fourth quarter 2024 (14× Y/Y), net loss $58.7M. How it makes money → · Every quarter →
Praxis Precision Medicines' latest quarter
Praxis Precision Medicines, Q4 2024: revenue $7.5M (14× year over year), operating margin -857.0%, net loss $58.7M, operating cash flow −$56.1M. The chart follows the revenue to costs, profit and cash.
Questions
When does PRAX report earnings?
Praxis Precision Medicines is expected to report on Nov 9, 2026.
What are analysts expecting from Praxis Precision Medicines?
EPS of −$3.63 for the quarter.
Does Praxis Precision Medicines usually beat earnings?
It beat the consensus EPS estimate in 75% of the quarters on record.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.